John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
The Ensign Group
ENSG
$10.4B
| $1.41M | ﹤0.01% |
11,309
+5,652
| +100% | +$678K |
|
|
LBAI
1702
DELISTED
Lakeland Bancorp Inc
LBAI
| $1.41M | ﹤0.01% |
116,225
+59,992
| +107% | +$770K |
|
|
LSEA
1703
DELISTED
Landsea Homes
LSEA
| $1.4M | ﹤0.01% |
96,468
-8,320
| -8% | -$105K |
|
|
IRBT
1704
DELISTED
iRobot
IRBT
| $1.4M | ﹤0.01% |
+159,554
| New | +$2.58M |
|
1705
Matrix Service
MTRX
$303M
| $1.4M | ﹤0.01% |
107,142
+54,648
| +104% | +$613K |
|
|
FORL
1706
DELISTED
Four Leaf Acquisition Corp
FORL
| $1.39M | ﹤0.01% |
130,000
| – | – |
|
1707
Sun Communities
SUI
$15.3B
| $1.39M | ﹤0.01% |
+10,800
| New | +$1.4M |
|
|
TGB
1708
Trekor Metals
TGB
$3.48B
| $1.38M | ﹤0.01% |
637,613
+312,524
| +96% | +$491K |
|
1709
Alta Equipment Group
ALTG
$202M
| $1.38M | ﹤0.01% |
106,603
+32,224
| +43% | +$370K |
|
1710
Intapp
INTA
$3.11B
| $1.38M | ﹤0.01% |
40,161
-231,794
| -85% | -$9.11M |
|
1711
iRadimed
IRMD
$1.12B
| $1.37M | ﹤0.01% |
31,193
+137
| +0.4% | +$6.05K |
|
1712
Otis Worldwide
OTIS
$27.2B
| $1.37M | ﹤0.01% |
13,800
-22,259
| -62% | -$2.06M |
|
1713
JPMorgan Chase
JPM
$948B
| $1.36M | ﹤0.01% |
6,800
-8,778
| -56% | -$1.58M |
|
1714
Five Below
FIVE
$14.3B
| $1.36M | ﹤0.01% |
+7,501
| New | +$1.45M |
|
1715
DigitalOcean
DOCN
$13.2B
| $1.36M | ﹤0.01% |
+35,508
| New | +$1.32M |
|
1716
Sprinklr
CXM
$1.75B
| $1.35M | ﹤0.01% |
110,328
+595
| +0.5% | +$7.58K |
|
1717
inTEST
INTT
$146M
| $1.35M | ﹤0.01% |
102,112
-62,266
| -38% | -$737K |
|
|
SPWR
1718
DELISTED
SunPower Corporation Common Stock
SPWR
| $1.35M | ﹤0.01% |
450,824
-1,830,442
| -80% | -$6.03M |
|
1719
Miller Industries
MLR
$649M
| $1.35M | ﹤0.01% |
26,963
+10,395
| +63% | +$453K |
|
1720
Bristow Group
VTOL
$1.36B
| $1.35M | ﹤0.01% |
49,660
+23,659
| +91% | +$630K |
|
1721
Outset Medical
OM
$80.8M
| $1.35M | ﹤0.01% |
40,526
+15,682
| +63% | +$794K |
|
|
CMPS
1722
Compass Pathways
CMPS
$2.06B
| $1.35M | ﹤0.01% |
162,123
+87,792
| +118% | +$885K |
|
|
HIVE
1723
HIVE Digital Technologies
HIVE
$828M
| $1.35M | ﹤0.01% |
399,466
-136,393
| -25% | -$486K |
|
1724
Kilroy Realty
KRC
$4.33B
| $1.34M | ﹤0.01% |
+36,890
| New | +$1.36M |
|
1725
Commercial Vehicle Group
CVGI
$126M
| $1.34M | ﹤0.01% |
208,742
-56,251
| -21% | -$363K |
|
Similar funds
John Overdeck's Q1 2024 Portfolio in Review
As of Q1 2024, John Overdeck held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
John Overdeck withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, John Overdeck opened a new position in Pfizer worth $234M.
- John Overdeck's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- John Overdeck added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- John Overdeck's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- John Overdeck fully exited Rivian in Q1 2024, selling an estimated $158M.
- John Overdeck's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- John Overdeck opened 408 new positions and closed 532 in Q1 2024.
- John Overdeck's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.